Drug recall · April 16, 2025
Venlafaxine Tablets recall
Why: Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.
- Lots / codes
Lot #: M314265, Exp.: 31 October 2025.
- Quantity
- 13,128 100-Count Bottles
- Company
- Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
- Distribution
- US Nationwide.
- Initiated
- March 21, 2025 · Voluntary: Firm initiated
- Classified
- April 4, 2025
- Reported
- April 16, 2025
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Venlafaxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.